Glenview Capital Management, LLC Teva Pharmaceutical Industries LTD Transaction History
Glenview Capital Management, LLC
- $4.05 Billion
- Q1 2025
A detailed history of Glenview Capital Management, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Glenview Capital Management, LLC holds 14,778,641 shares of TEVA stock, worth $245 Million. This represents 5.6% of its overall portfolio holdings.
Number of Shares
14,778,641
Previous 8,456,324
74.76%
Holding current value
$245 Million
Previous $186 Million
21.88%
% of portfolio
5.6%
Previous 4.71%
Shares
5 transactions
Others Institutions Holding TEVA
# of Institutions
660Shares Held
627MCall Options Held
27.9MPut Options Held
21.8M-
Black Rock Inc. New York, NY43MShares$711 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E939MShares$646 Million39.53% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$625 Million5.98% of portfolio
-
Menora Mivtachim Holdings Ltd.29.2MShares$483 Million2.92% of portfolio
-
Exor Capital LLP London, X027.9MShares$461 Million12.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...